CTNI-33. CSNO2012001 STUDY: A PHASE III TRIAL ON ADJUVANT TEMOZOLOMIDE CHEMOTHERAPY WITH OR WITHOUT INTERFERON-ALPHA IN NEWLY DIAGNOSED HIGH-GRADE GLIOMAS
Authors: ZhongPing Chen, Chengcheng Guo, JianGen Chen
Published: 2022-11-14
DOI:
10.1093/neuonc/noac209.298
Source:
Full article
Abstract
Abstract